Teva’s Rx For GDUFA III: Treat Complex Generics More Like NDAs

 
• By Sue Sutter
  
Silhouette of diving board at sunset
FDA and industry want to use the successes of GDUFA II as a springboard to a new generic drug user fee agreement. • Source: Shutterstock
Pink Sheet Podcast

Learn what's happening at the US FDA. On the go.

Derrick Gingery and the team bring you a weekly "Drug Fix".

SpotifyApple PodcastsWebsite

More from Generics

More from Biosimilars & Generics